ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,275.38
0.54%
Dow Jones
38,686.32
1.51%
Gold vs US Dollar
2,327.355
0.00%
Brent Oil
81.295
0.00%
Bitcoin
67,757.62
0.05%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Liquidia Corporation (LQDA)

  7. Liquidia Corporation (LQDA) News

Liquidia (LQDA)

Liquidia Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:LQDA
DateTimeSourceHeadlineSymbolCompany
31/05/202422:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LQDALiquidia Corporation
29/05/202413:00GlobeNewswire Inc.Liquidia Corporation to Present at the 2024 Jefferies Global Healthcare ConferenceNASDAQ:LQDALiquidia Corporation
14/05/202421:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LQDALiquidia Corporation
13/05/202422:43GlobeNewswire Inc.Liquidia Corporation Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:LQDALiquidia Corporation
13/05/202422:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LQDALiquidia Corporation
10/05/202413:00GlobeNewswire Inc.Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) 2024 International Conference on Its Open-Label Safety Study of L606 (Liposomal Treprostinil) in Patients with PAH and PH-ILDNASDAQ:LQDALiquidia Corporation
07/05/202413:30GlobeNewswire Inc.Liquidia Corporation to Present at BofA Securities Health Care Conference 2024NASDAQ:LQDALiquidia Corporation
07/05/202413:00GlobeNewswire Inc.Liquidia Corporation to Report First Quarter 2024 Financial Results on May 14, 2024NASDAQ:LQDALiquidia Corporation
02/04/202414:00GlobeNewswire Inc.Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:LQDALiquidia Corporation
01/04/202411:00GlobeNewswire Inc.Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA™ (treprostinil) inhalation powderNASDAQ:LQDALiquidia Corporation
13/03/202410:00GlobeNewswire Inc.Liquidia Corporation Reports Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:LQDALiquidia Corporation
06/03/202411:30GlobeNewswire Inc.Liquidia Corporation to Report Full Year 2023 Financial Results on Wednesday, March 13, 2024NASDAQ:LQDALiquidia Corporation
05/03/202400:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LQDALiquidia Corporation
30/01/202411:30GlobeNewswire Inc.Liquidia Corporation Announces Poster Presentation at the Pulmonary Vascular Research Institute 2024 Annual CongressNASDAQ:LQDALiquidia Corporation
25/01/202412:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LQDALiquidia Corporation
25/01/202411:00GlobeNewswire Inc.Liquidia Corporation Provides Update on New Drug Application for YUTREPIA™ (treprostinil) inhalation powderNASDAQ:LQDALiquidia Corporation
23/01/202412:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LQDALiquidia Corporation
19/01/202412:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LQDALiquidia Corporation
19/01/202411:30GlobeNewswire Inc.Liquidia Corporation Announces Updates to Operations LeadershipNASDAQ:LQDALiquidia Corporation
16/01/202422:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LQDALiquidia Corporation
16/01/202422:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LQDALiquidia Corporation
16/01/202422:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LQDALiquidia Corporation
16/01/202412:42Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:LQDALiquidia Corporation
08/01/202421:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LQDALiquidia Corporation
08/01/202413:22GlobeNewswire Inc.Liquidia Corporation Files Response to United Therapeutics Lawsuit and Files CounterclaimsNASDAQ:LQDALiquidia Corporation
05/01/202411:45GlobeNewswire Inc.Liquidia Provides Update on Clinical Pipeline Targeting PAH and PH-ILDNASDAQ:LQDALiquidia Corporation
05/01/202402:37Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LQDALiquidia Corporation
04/01/202414:10GlobeNewswire Inc.Liquidia Corporation Announces $100 Million in New FinancingsNASDAQ:LQDALiquidia Corporation
04/01/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:LQDALiquidia Corporation
02/01/202411:45GlobeNewswire Inc.Liquidia Corporation to Present at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:LQDALiquidia Corporation
 Showing the most relevant articles for your search:NASDAQ:LQDA

Your Recent History

USOTC
DSWR
Deseo Swimwear (PK)
ASX
RLG
RooLife
USOTC
BRSI
Ballistic Recovery Systems (CE)
NYSE
WLS
William Lyon
CSE
EI
Eurogas
USOTC
BPCF
Blackstone Private Credit (PK)
BIT
S32469
Societe Generale Effekten
NYSE
CYN
City National
EU
FR001400N4Q6
BFCM BQUE Feder Credit M...
LSE
0NZ8
Nordecon As
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved